Freshpet, Inc. to Participate in the 2018 ICR Conference

SECAUCUS, N.J., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Freshpet, Inc. (“Freshpet” or the “Company”) (NASDAQ: FRPT) today announced that Billy Cyr, Chief Executive Officer, Dick Kassar, Chief Financial Officer, and Scott Morris, Chief Operating Officer, will participate in the 2018 ICR Conference.

The presentation will be on Tuesday, January 9, 2018 at 10:00 a.m. ET, can be accessed live over the Internet hosted at the "Investors" section of the Company's website at www.freshpet.com and will be archived online through Tuesday, January 23, 2018.

About Freshpet

Freshpet has a single-minded mission – to improve the lives of dogs and cats everywhere through the power of fresh, natural food. Packed with vitamins and proteins, Freshpet foods offer fresh meats, poultry, and vegetables farmed locally. At our Freshpet Kitchens, we thoughtfully prepare these natural ingredients and everyday essentials, cooking them in small batches at lower temperatures to preserve key nutrients. That way, your pet gets the best. Freshpet refrigerated foods and treats are kept cool from the moment they are made until they arrive at Freshpet Fridges in your local market.

Freshpet foods are available in select mass, grocery, natural food, club, and pet specialty retailers across the United States, Canada and are currently testing in the United Kingdom. From the care Freshpet takes to source their ingredients and make their food, to the moment it reaches your home, Freshpet’s integrity, transparency and social responsibility are the way they like to run their business. To learn more, visit www.freshpet.com.

Connect with Freshpet:

https://www.facebook.com/Freshpethttps://twitter.com/Freshpethttp://instagram.com/Freshpethttp://pinterest.com/Freshpethttps://plus.google.com/+Freshpethttps://en.wikipedia.org/wiki/Freshpethttps://www.youtube.com/user/freshpet400

Investor Contact: Katie Turner646-277-1228[email protected]

Media Contact: Michael Fox203-682-8218[email protected] 

You May Also Be Interested In

• ProMIS Neurosciences Reports First Human Evidence of Amyloid-Beta Oligomer Target Engagement by PMN310 at AAIC 2026
• Draig Therapeutics Closes Oversubscribed $65 Million Series B to Accelerate Development of Highly Specific AMPA and GABAA Receptor Modulators in Neuropsychiatric Disorders
• Beyond the Screen: Hero Esports CEO Highlights Role of Esports in Creating Shared Urban Experiences at LEAP East 2026